-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - Applicability Summary Table Template
Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table
Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association
Comparison Strength of Evidence Conclusions With Description
-
effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
May 01, 2011 - Data Analysis
Evidence tables and qualitative description of results
were presented for all included … Results
Description of Included Studies
The search strategy identified 9,357 citations; 83
unique … The most common sources of
potential bias were inadequate description of the
randomization procedure
-
effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of
studies
Domain Description … Example summary table characterizing the applicability of a body of studies
Domain Description of applicability … Example summary table for body of evidence
Comparison Strength of
Evidence
Conclusions with description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
March 29, 2011 - participant characteristics (age, diagnosis,
symptom severity, etc.), intervention characteristics (description … author, year of publication, study location
(e.g., country, city, state) and time period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a
description
-
effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - Vignettes were used to
provide all interviewees with a common point of refer-
ence13,14 and a “listenable” description … intended to provide quantitative data;
rather, they were intended to provide a thorough and accurate
description … Potential Barriers
Major Themes Description
Impact on satisfaction Members, physicians, formulary committee
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
January 01, 2009 - Applicability Summary Table Template
Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table
Domain Description of Applicability Evidence for a Key Question … angiotensin-converting enzyme; NYHA = New York Heart Association
Comparison Strength of Evidence Conclusions With Description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - Elements to be included in a summary table characterizing the applicability of a body of
studies
Domain Description … Example summary table characterizing the applicability of a body of studies
Domain Description of applicability … Example summary table for body of evidence
Comparison Strength of
Evidence
Conclusions with description
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - author, year of
publication, study location (e.g., country, city, state) and time period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - author, year of
publication, study location (e.g., country, city, state) and time period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
May 24, 2010 - held concepts of high quality
including the following: a formal randomized controlled study; clear description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - criteria: (1) appropriateness of the randomization scheme, (2) appropriateness of the
blinding, and (3) description … concepts of high quality, including the
following: a formal randomized controlled design; a clear description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - contain some common elements (e.g., author,
publication year, study location, time period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a
description
-
effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
January 01, 2011 - The supplement concludes with a description of how Directed Acyclic Graphs (DAGs)
can be used to select … The supplement
concludes with a description of how Directed Acyclic
Graphs (DAGs) can be used to select
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
January 27, 2014 - Peer Reviewer#1 Introduction The description needs to be
clarified regarding the clinical
indications … Peer Reviewer#1 Methods There is no description of
whether or not the authors
included grey literature … Peer Reviewer#1 Methods Within the description of the
data synthesis methods the
authors need to justify … An explanation of how pain was evaluated is
included in each study description.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
March 26, 2013 - Please see the preceding section for a detailed description of the populations, interventions, and outcomes … features: lowest likelihood of confounding due to comparison to a randomized
controlled group; a clear description … In the event of protocol amendments, the date of each
amendment will be accompanied by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - However, when we read a
submitted version of this paper we found their description
of the intervention
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
March 07, 2012 - None of the studies looked specifically at children with
joint swelling; we added this to the description … operating characteristic curve for different tests and
diagnoses could be improved with a detailed figure
description … We have reworded the outcome description for KQ5.